Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | CES2 | O00748 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL2587274 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL715799 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL4438557 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL2587267 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL715250 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL2583073 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL6009607 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL715486 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL714199 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL27640240 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130116120-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2013-05-09 | — | — | US | disclosed |
| US-8357636-B2 | Alkoxylated alkylamines/alkyl ether amines with peaked distribution | AKZO NOBEL N.V. (NL) | 2013-01-22 | — | — | US | disclosed |
| EP-2032523-B1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL NV (NL) | 2012-06-20 | — | — | EP | disclosed |
| US-20120053054-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2012-03-01 | — | — | US | disclosed |
| US-8049039-B2 | Process for preparation of alkoxylated alkylamines/alkyl ether amines with peaked distribution | AKZO NOBEL N.V. (NL) | 2011-11-01 | — | — | US | disclosed |
| US-8034979-B2 | Reacting primary alkylamine with alkylene oxide in absence of any functional proportion of alkali catalyst to yield first intermediate followed by reacting intermediate with additional moles of alkylene oxide at temperature of 90-130 degrees C. in absence of alkali catalyst to yield ethoxylated product | MONSANTO TECHNOLOGY LLC (US) | 2011-10-11 | — | — | US | disclosed |
| US-20100056376-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | MONSANTO TECHNOLOGY LLC (US) | 2010-03-04 | — | — | US | disclosed |
| US-20090209788-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2009-08-20 | — | — | US | disclosed |
| CN-101511175-A | Alkoxylated alkylamines or alkoxylated alkyl ether amines with peaked distribution | AKZO NOBEL NV (NL) | 2009-08-19 | — | — | CN | disclosed |
| CN-101479232-A | Process for preparation of alkoxylated alkylamines / alkyl ether amines with peaked distribution | AKZO NOBEL NV (NL) | 2009-07-08 | — | — | CN | disclosed |
| EP-2032523-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007109791-A9 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL NV (NL) | 2009-01-15 | — | — | WO | disclosed |
| EP-2003965-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2008-12-24 | — | — | EP | disclosed |
| US-20080261814-A1 | Alkoxylated Alkylamines/Alkyl Ether Amines With Peaked Distribution | MONSANTO TECHNOLOGY LLC (US) | 2008-10-23 | — | — | US | disclosed |
| WO-2007147866-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-12-27 | — | — | WO | disclosed |
| CN-101080167-A | Alkoxylated alkylamines / alkyl ether amines with peaked distribution | AKZO NOBEL INC (NL) | 2007-11-28 | — | — | CN | disclosed |
| WO-2007109791-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-09-27 | — | — | WO | disclosed |
| EP-1793667-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006034459-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209788-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALKBH3, ALKBH2, ALKBH5 | THRB 4617/4885HTT 1612/4885MEN1 1829/4885 |
| US-20130116120-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALK, ALKBH3, NAT1 | THRB 3906/4885HTT 688/4885MEN1 2271/4885 |
| US-20100056376-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALK, ALKBH3, NAT1 | THRB 3906/4885HTT 688/4885MEN1 2271/4885 |
| US-20120053054-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALKBH3, ALKBH2, ALKBH1 | THRB 4460/4885HTT 1421/4885MEN1 2669/4885 |
| US-20080261814-A1 | Alkoxylated Alkylamines/Alkyl Ether Amines With Peaked Distribution | ALKBH3, ALKBH2, ALKBH1 | THRB 4460/4885HTT 1421/4885MEN1 2669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.